Stock Spotlight: EBOS Group Ltd (ASX:EBO)

About EBOS Group Ltd

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.



Key Stats

Source: Yahoo Finance. Data as of 05/09/25.

Price Performance

Growth Potential

  • Recent share price correction has resulted in EBO’s valuation looking more attractive along with offering a solid dividend yield.
  • While EBO earnings are not completely immune to economic conditions, we do believe there are elements of defensive quality to EBO’s earnings which may warrant a premium to the market.
  • Leveraged to positive industry trends across healthcare (ageing population + increased pharma & medical spend) and increased pet spend (pet ownership + pert humanization).
  • Market leading positions including - pharmaceutical wholesaler (Aus & NZ), community pharmacy network in Australia (TerryWhite Chemmart), ANZ/NZ hospital medicines wholesaler and ANZ’s largest dry dog food brand in pet specialty
  • Bolt on acquisitions to supplement organic growth – the Company has a successful history of making acquisitions.
  • New contract wins.


Key Risks

  • Changes to the industry structure or competitive landscape which leads to increased customer churn (loss of contracts).
  • Poor execution.
  • Value destructive M&A.
  • Change in senior management.
  • Cut to dividends due to balance sheet or earnings pressure.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

CPI Explained: Why One Number Drives Markets, Rates and Portfolios

March 19, 2026
CPI moves markets, rates and portfolios every month. Understand how the transmission works and what investors should focus on beyond the headline number.

Gold Is Holding Near $5,000: Why the Fed Will Decide What Happens Next

March 18, 2026
Despite an escalating Middle East conflict, gold is stalling near $5,000. Find out why policy clarity, and not geopolitics, will determine the next big move.

RBA Hikes to 4.10%: Why the Latest Move Is Sending Mixed Signals Across Markets

March 18, 2026
The RBA raised the cash rate to 4.10% in in a divided 5–4 decision. We break down market reactions, policy signals and investment positioning implications.

The VIX in a Crisis: What the Market’s Fear Gauge Reveals

March 13, 2026
What does the VIX reveal during market turmoil? Learn how the market’s fear gauge measures volatility, investor sentiment, and what it means for investors.

ASX Loses $90bn as Iran Conflict Escalates — What It Means for Retirement Savings

March 12, 2026
As geopolitical tensions wiped $90bn from the ASX, investors are asking what it means for super. Here’s how market volatility can impact retirement savings.

Asia on the Brink as the Oil Shock Hits Hard

March 11, 2026
An escalating oil shock is testing Asia’s energy dependence, raising inflation risks, pressuring currencies and increasing volatility across global equity markets.

Playing the Long Game: Why Time in the Market Beats Timing the Market

March 6, 2026
Explore why time in the market consistently outperforms market timing and how disciplined, long-term investing helps build wealth through compounding.

Stock Spotlight: oOh!media Limited (ASX:OML)

March 5, 2026
This week's Stock Spotlight is ASX-listed oOh!media Limited. About oOh!media Limited. oOh!media Limited engages in the outdoor media, and production and advertising businesses in Australia and New Zealand. It offers large format digital and classic roadside screens; large and small format digital and classic signs located in retail precincts, such as shopping centres, airport terminals, lounges and in flight; digital and classic street furniture signs; digital and classic format advertising in public transport corridors, including rail; and digital and classic signs in high dwell time environments, such as universities and office buildings. The company also provides advertising creative and printing services. oOh!media Limited was founded in 1989 and is based in North Sydney, Australia. Source: EODHD Key Stats

Stock Spotlight: Goodman Group (ASX:GMG)

March 5, 2026
Get the latest news on Goodman Group (ASX:GMG), including stock performance, technical analysis, forecasts & key insights. See if GMG supports your goals.

The New Energy Paradox: Why the Gulf Crisis Is Supporting Both Oil and Renewables

March 5, 2026
Gulf tensions are accelerating oil investment and the energy transition. Analyse how the conflict is influencing oil markets, renewables and ASX opportunities.